Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 1
2009 3
2010 2
2011 3
2012 2
2013 4
2014 5
2015 4
2016 7
2017 5
2018 2
2019 4
2020 4
2021 2
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Particle therapy for prostate cancer: The past, present and future.
Ishikawa H, Tsuji H, Murayama S, Sugimoto M, Shinohara N, Maruyama S, Murakami M, Shirato H, Sakurai H. Ishikawa H, et al. Among authors: murayama s. Int J Urol. 2019 Oct;26(10):971-979. doi: 10.1111/iju.14041. Epub 2019 Jul 8. Int J Urol. 2019. PMID: 31284326 Free PMC article. Review.
Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence.
Yasui K, Kondou R, Miyata H, Iizuka A, Ashizawa T, Nagashima T, Ohshima K, Urakami K, Muramatsu K, Sugino T, Yamaguchi K, Ogawa H, Onoe T, Harada H, Asakura H, Murayama S, Nishimura T, Goto S, Okada S, Mukaigawa T, Hamauchi S, Yokota T, Onozawa Y, Akiyama Y. Yasui K, et al. Among authors: murayama s. Anticancer Res. 2022 Sep;42(9):4417-4428. doi: 10.21873/anticanres.15942. Anticancer Res. 2022. PMID: 36039416
Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M, Yasui K, Oota N, Ogawa H, Onoe T, Maki S, Ito Y, Hayashi K, Asakura H, Murayama S, Mitsuya K, Deguchi S, Nakamura K, Hayashi N, Nishimura T, Harada H. Hirata M, et al. Among authors: murayama s. Radiat Oncol. 2022 Dec 28;17(1):213. doi: 10.1186/s13014-022-02185-1. Radiat Oncol. 2022. PMID: 36578021 Free PMC article.
Correction: Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M, Yasui K, Oota N, Ogawa H, Onoe T, Maki S, Ito Y, Hayashi K, Asakura H, Murayama S, Mitsuya K, Deguchi S, Nakamura K, Hayashi N, Nishimura T, Harada H. Hirata M, et al. Among authors: murayama s. Radiat Oncol. 2023 Mar 3;18(1):45. doi: 10.1186/s13014-023-02206-7. Radiat Oncol. 2023. PMID: 36869325 Free PMC article. No abstract available.
Patterns of proton therapy use in pediatric cancer management in 2016: An international survey.
Journy N, Indelicato DJ, Withrow DR, Akimoto T, Alapetite C, Araya M, Chang A, Chang JH, Chon B, Confer ME, Demizu Y, Dendale R, Doyen J, Ermoian R, Gurtner K, Hill-Kayser C, Iwata H, Kim JY, Kwok Y, Laack NN, Lee C, Lim DH, Loredo L, Mangona VS, Mansur DB, Murakami M, Murayama S, Ogino T, Ondrová B, Parikh RR, Paulino AC, Perkins S, Ramakrishna NR, Richter R, Rombi B, Shibata S, Shimizu S, Timmermann B, Vern-Gross T, Wang CJ, Weber DC, Wilkinson JB, Witt Nyström P, Yock TI, Kleinerman RA, Berrington de Gonzalez A. Journy N, et al. Among authors: murayama s. Radiother Oncol. 2019 Mar;132:155-161. doi: 10.1016/j.radonc.2018.10.022. Epub 2018 Nov 7. Radiother Oncol. 2019. PMID: 30414759
53 results